The biopharma industry is in need of talented minds to take promising pipelines to the clinic and beyond. Venture capitalists have nominated prominent founders and entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. These entrepreneurs have proven their expertise in hitting milestones, be it in the lab or…
A new wave of biomimicry companies is harnessing the power of nature to develop innovative treatments for various diseases. By studying the properties of plants and animals, these companies are creating novel therapeutic targets and drugs that mimic natural protective mechanisms. From tick saliva to snake venom, these biomimicry companies are unlocking the secrets of…
The biotech industry has seen a surge in the number of unicorns, with over 1,200 companies worldwide achieving valuations of over $1 billion. However, biotech unicorns are relatively rare, with only a few companies making it to the top. This article takes a closer look at 12 biotech unicorns that are making waves in the…
A recent surge in therapeutic progress has brought new hope to patients suffering from Duchenne muscular dystrophy, a severe form of inherited muscular dystrophy. Several biotech companies, including Wave Life Sciences, Sarepta Therapeutics, Capricor Therapeutics, Edgewise Therapeutics, Italfarmaco, and Avidity Biosciences, are making significant strides in developing innovative treatments, including RNA medicines, gene therapies, and…
Lithuania’s life sciences industry is experiencing a significant boom, with over 550 biotech companies and a growing number of startups. The country is home to several promising ventures, including Atrandi Biosciences, Biomatter Designs, CasZyme, Delta Biosciences, Genie Biotech, and Vital3D, which are pushing the boundaries of protein engineering, gene editing, and microfluidics. This growth is…
The biotech industry in Europe is experiencing significant growth, with numerous trends shaping the sector. A list of top European biotech companies that have received sizable seed funding in the past year has been compiled, highlighting companies that are directing funds towards research and development (R&D) programs in various therapeutic areas. The industry is witnessing…
The biopharma industry is witnessing a surge in investment in the immunology field, with over 10 buyouts of immunology and inflammation (I&I) drug developers this year. Several biotech companies have raised impressive funds to advance the development of their immunology-related research and development (R&D). These companies are working on innovative treatments for various diseases, including…
